Global Sepsis Diagnostics Market 2017-2021

SKU ID : TNV- 10616845

Publishing Date : 13-Oct-2017

No. of pages : 86

PRICE
2500
4000

  • About Sepsis Diagnostics

    Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
    Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

    Technavio’s analysts forecast the global sepsis diagnostics market to grow at a CAGR of 6.74% during the period 2017-2021.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • bioMérieux
    • T2 Biosystems
    Other prominent vendors
    • Alere
    • Abionic
    • AdvanDx
    • Aethlon Medical
    • AusDiagnostics
    • Beckman Coulter
    • Beckton Dickinson
    • Momentum Bioscience
    • Bio-Rad Laboratories
    • Bruker
    • Cepheid
    • Curetis
    • CytoSorbents
    • Fast Track Diagnostics
    • F. Hoffmann-La Roche
    • Fujirebio Europe
    • Hansa Medical
    • Hain Lifescience
    • Immunexpress
    • Inflammatix
    • Merck
    • miacom diagnostics
    • Mitsubishi Chemical Europe
    • Nanōmix
    • QIAGEN
    • Radiometer
    • Response Biomedical
    • Sepset Biosciences
    • Siemens Healthineers
    • TCS Biosciences
    • Thermo Fisher Scientific
    Market driver
    • Rising prevalence of hospital acquired infection (HAIs) globally
    • For a full, detailed list, view our report

    Market challenge
    • High cost of sepsis treatment
    • For a full, detailed list, view our report

    Market trend
    • Increasing use of biomarkers for sepsis
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2021 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports